Technology-Enabled Skin Cancer Screening for Stem Cell Transplant Survivors
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to improve early detection of skin cancer in individuals who have undergone stem cell transplants. Participants will receive educational materials and regular text message reminders to help them identify skin changes early. Some participants' doctors will also receive resources to support skin checks during visits, and some will receive a tool (dermatoscope) to better examine skin changes. This trial is for stem cell transplant survivors who had the procedure at City of Hope between two and five years ago and who have a mobile phone for receiving texts. As an unphased trial, it offers a unique opportunity to contribute to research that could enhance post-transplant care and early cancer detection.
Do I need to stop my current medications for this trial?
The trial information does not specify whether you need to stop taking your current medications. It is best to discuss this with the trial coordinators or your doctor.
What prior data suggests that this intervention is safe for stem cell transplant survivors?
Research has shown that educational programs for both patients and doctors are generally safe and well-received. Studies indicate that patient support programs can improve cancer care by helping patients understand their treatment and feel supported, without causing harm. For doctors, educational programs enhance their ability to detect skin cancer early, leading to better patient outcomes. The safety of these educational efforts is well-documented, as they focus on increasing knowledge and awareness.
Additionally, using a dermatoscope, a tool for closely examining skin spots, is common in skin care and is considered safe and non-invasive. Although specific safety data for these programs is not provided, the methods used are widely accepted in medical practice, suggesting they are well-tolerated by participants.12345Why are researchers excited about this trial?
Researchers are excited about this trial because it explores innovative ways to enhance skin cancer screening for stem cell transplant survivors. Unlike standard screenings, which typically rely on patient or physician-initiated consultations, this approach integrates regular educational interventions and digital communication to keep participants informed and vigilant. One unique feature is the use of a dermatoscope by trained physicians, enhancing diagnostic precision through high-quality imaging. The trial also empowers patients with knowledge and regular reminders, potentially leading to earlier detection and improved outcomes. Overall, this method could streamline the screening process and make it more proactive and accessible for patients.
What evidence suggests that this trial's interventions could be effective for early detection of skin cancer in stem cell transplant survivors?
Research has shown that educational programs can help individuals who have undergone stem cell transplants detect skin cancer early. In this trial, participants in Group I will receive educational materials and regular text messages to support early detection. Group II participants will receive the same educational materials and text messages, with their physicians encouraged to perform skin examinations. Group III participants will receive all these interventions, and their physicians will also receive a dermatoscope and training to enhance early detection. One study found that patients who learned about preventing skin cancer retained this information well. Another study demonstrated that programs assisting patients in navigating the healthcare system increased their participation in cancer screenings. When doctors are involved, these efforts often prove more effective, as they can guide and encourage patients to check their skin regularly. Tools like a dermatoscope, which enhances the visibility of skin details, can also improve early detection. Overall, these combined strategies can lead to better outcomes by identifying skin cancer sooner.16789
Who Is on the Research Team?
Saro H Armenian
Principal Investigator
City of Hope Comprehensive Cancer Center
Are You a Good Fit for This Trial?
This trial is for stem cell transplant survivors who are 2-5 years post-transplant, can read and write in English or Spanish, have seen a primary care provider recently or plan to within a year, and can receive text messages. Those with active cancer or acute illness that limits participation cannot join.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Intervention
Participants receive a study packet on skin cancer and text messages every 3 weeks for 9 months. Physicians may receive additional educational materials and tools.
Follow-up
Participants are monitored for changes in skin cancer screening practices and health promotion activities.
What Are the Treatments Tested in This Trial?
Interventions
- Computer-Assisted Intervention
- Dermatoscope
- Educational Intervention
- Educational Intervention (Physician)
- Questionnaire Administration
- Text Message
Find a Clinic Near You
Who Is Running the Clinical Trial?
City of Hope Medical Center
Lead Sponsor
National Cancer Institute (NCI)
Collaborator